Understanding the Mechanisms of Resistance to T Cell-based Immunotherapies to Develop More Favorable Strategies in Multiple Myeloma

Understanding the Mechanisms of Resistance to T Cell-based Immunotherapies to Develop More Favorable Strategies in Multiple Myeloma

Bibliographic Details
Main Authors:	Sungwoo Ahn, Noémie Leblay, Paola Neri
Format:	Article
Language:	English
Published:	Wolters Kluwer 2021-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000575

Similar Items

Deregulation of Adaptive T Cell Immunity in Multiple Myeloma: Insights Into Mechanisms and Therapeutic Opportunities
by: Noémie Leblay, et al.
Published: (2020-05-01)

Immunotherapy in Multiple Myeloma
by: Cinnie Yentia Soekojo, et al.
Published: (2020-03-01)

Immunotherapy for Multiple Myeloma
by: Nicolaus Kröger, et al.
Published: (2012-01-01)

Immunotherapy in Multiple Myeloma
Published: (2019)

Cellular immunotherapy in multiple myeloma
by: Manh-Cuong Vo, et al.
Published: (2019-09-01)

Introduction to “Immunotherapies for Multiple Myeloma”
by: Massimo Offidani, et al.
Published: (2020-11-01)

The Role of Immunotherapy in Multiple Myeloma
by: Mehmet Kocoglu, et al.
Published: (2016-01-01)

Editorial: Immunotherapy in Multiple Myeloma
by: Nicola Giuliani, et al.
Published: (2019-08-01)

BCMA-targeted immunotherapy for multiple myeloma
by: Bo Yu, et al.
Published: (2020-09-01)

Development of Novel Immunotherapies for Multiple Myeloma
by: Ensaf M. Al-Hujaily, et al.
Published: (2016-09-01)

Immunotherapy of Multiple Myeloma: Promise and Challenges
by: Abramson HN
Published: (2021-09-01)

Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions
by: Ivetta Danylesko, et al.
Published: (2012-01-01)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Alfonso Serrano-del Valle, et al.
Published: (2019-04-01)

Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma
by: Lu Zhang, et al.
Published: (2012-01-01)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
by: Yi Lin, et al.
Published: (2020-07-01)

Drug resistance mechanisms in multiple myeloma
by: Scott, F. M.
Published: (1998)

Drug resistance mechanisms in multiple myeloma
by: Doherty, Catherine Jean
Published: (1997)

Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01)

The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma
by: Arthur Bobin, et al.
Published: (2020-05-01)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Ken Maes, et al.
Published: (2019-07-01)

Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance
by: Lisa C. Holthof, et al.
Published: (2020-04-01)

Familial multiple myeloma. Two more families
by: Várkonyi Judit, et al.
Published: (2009-12-01)

Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
by: Jennifer Sun, et al.
Published: (2020-01-01)

Immunotherapy: A Novel Era of Promising Treatments for Multiple Myeloma
by: Maria Castella, et al.
Published: (2018-11-01)

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Alfonso Serrano Del Valle, et al.
Published: (2019-11-01)

Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review
by: Hiroko Nishida
Published: (2021-05-01)

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
by: Dalia Quwaider, et al.
Published: (2017-04-01)

Favorable kidney recovery by extracorporeal light chain removal and anti-myeloma treatments in patients with newly diagnosed multiple myeloma and acute renal failure
by: Giorgio Silvestrini, et al.
Published: (2020-01-01)

Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma
by: Wen-Chi Yang, et al.
Published: (2015-01-01)

Recent advances in understanding multiple myeloma
by: Parameswaran Hari
Published: (2017-12-01)

Molecular characterization of rare thoraco-abdominal tumours
by: Leblay, Noémie
Published: (2018)

Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy
by: Helmi Alfarra, et al.
Published: (2020-11-01)

Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve?
by: Thanh-Nhan Nguyen-Pham, et al.
Published: (2012-01-01)

Targeting Multiple-Myeloma-Induced Immune Dysfunction to Improve Immunotherapy Outcomes
by: Sergio Rutella, et al.
Published: (2012-01-01)

CT103A, a forward step in multiple myeloma immunotherapies
by: Jie Xu, et al.
Published: (2021-04-01)

Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor
by: Nicola Sgherza, et al.
Published: (2021-09-01)

Targeting the Resistance in Multiple Myeloma
by: Micaela Freitas, et al.
Published: (2019-04-01)

Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma
by: Lorraine N. Davis, et al.
Published: (2021-04-01)

Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
by: Ilaria Saltarella, et al.
Published: (2020-01-01)

Immunotherapy in Myeloma A Theme Issue in Honor of Prof. Dr. Gösta Gahrton
Published: (2022)